Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis.
Mahnoor KhattakAnees Ur RehmanTuba MuqaddasRabia HussainMuhammad Fawad RasoolZikria SaleemMesfer Safar AlmalkiSamar Adel AlturkistaniShuruq Zuhair FirashOseid Mohammed AlzahraniAmmar Abdulraheem BahauddinSafa Almarzooky AbuhussainMuath Fahmi NajjarHossameldeen Mahmoud Ali ElsabaaAbdul HaseebPublished in: Annals of medicine (2024)
A negative impact of DM was found on recurrence and extended treatment duration in TB patients treated with DOTS therapy. DM type 2 is responsible for the TB treatment prolongation and TB recurrence rates. By implementing effective management strategies and advancing research, the challenges can be mitigated, arising due to the complex interaction between DM and TB.
Keyphrases
- mycobacterium tuberculosis
- end stage renal disease
- type diabetes
- cardiovascular disease
- chronic kidney disease
- ejection fraction
- stem cells
- mesenchymal stem cells
- skeletal muscle
- peritoneal dialysis
- mass spectrometry
- bone marrow
- quality improvement
- weight loss
- human immunodeficiency virus
- drug induced
- smoking cessation
- adverse drug
- chemotherapy induced